P
BHVN icon

Pfizer’s Biohaven BHVN Stock Holding History

Pfizer’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8M Hold
505,645
– – 4.7% 6
2026
Q1 		$4.23M Hold
505,645
– – 1.77% 10
2025
Q4 		$5.71M Hold
505,645
– – 2.41% 10
2025
Q3 		$7.59M Hold
505,645
– – 1.74% 11
2025
Q2 		$7.13M Hold
505,645
– – 1.24% 9
2025
Q1 		$12.2M Hold
505,645
– – 2.43% 7
2024
Q4 		$18.9M Buy
+505,645
New +$23.6M 0.73% 8

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pfizer's BHVN Position: Q2 2026 in Review

Pfizer held its Biohaven (BHVN) position steady in Q2 2026 at 505,645 shares worth $8M. The position accounts for 4.7% of the portfolio, ranked #6.

Pfizer first reported a position in BHVN in Q4 2024 and has held it in 7 quarters since. The position peaked at $18.9M in Q4 2024. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Pfizer held 505,645 shares of Biohaven worth $8M as of Q2 2026.
  • Pfizer left its Biohaven share count unchanged in Q2 2026.
  • Biohaven made up 4.7% of Pfizer's portfolio in Q2 2026, its #6 holding.
  • Pfizer first reported a position in Biohaven in Q4 2024 and has held it in 7 quarters since.
  • Pfizer's Biohaven position peaked at $18.9M in Q4 2024.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Pfizer's 13F filing for Q2 2026, filed 13 Aug 2026.